Table:
begin	end	state
1	31	signal peptide
32	47	non-cytoplasmic
48	69	transmembrane
70	75	cytoplasmic
76	96	transmembrane
97	101	non-cytoplasmic
102	122	transmembrane
123	134	cytoplasmic
135	159	transmembrane
160	164	non-cytoplasmic
165	185	transmembrane
186	233	cytoplasmic
234	249	transmembrane
250	253	cytoplasmic
254	264	non-cytoplasmic
265	289	transmembrane
290	303	cytoplasmic
304	322	transmembrane
323	327	non-cytoplasmic
328	349	transmembrane
350	359	cytoplasmic
360	385	transmembrane
386	389	non-cytoplasmic
390	412	transmembrane
413	432	cytoplasmic

Input:
>RR42_RS11305
MKHIKGMRWWMVSLVTMGLIVNYLARNTLSVAAPTMMSELHMTTQQYSYVVVAWQVCYAM
MQPVAGLVLDAIGTKIGFGIFALAWSLACAAAALASGWQGLAFFRGLLGLAEAAGIPGGV
KATTEWFPAKERSIAIGWFNIGSSIGALCAPPLVVWTILNGGWQRAFIIVGALGVAWTVL
WMLCYKHPKNQQRLSDQEREYILAGQEAQHKDANMAKASWLEIMRSRNFWSIAIPRFLSE
PAWQTFNAWIPLYMATERHMNIKEIAMFAWLPFLAADIGCVLGGYLSPWFHKHLKVSLFT
SRKLVMLVGCLAMIGPACVGLVDSPYSAIALLCVGGFAHQTLSGALYSITSDAFGKNEVA
TATGLAGMSGYLGATLFTLLFGIAVTHIGYSPLFVLLAVFDLIAAAIVFLMARERAAPGA
AAANLGSPALHS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server